Stock Ownership/CUE

CUE BIOPHARMA INC (CUE): Ownership & Insider Activity

Hedge funds and institutional managers reporting a position in CUE. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.

Reported Holders
3
13F filers
Aggregate Value
$4.2M
Across holders
Last Price
$25.57
2026-10-02
Sector
—
GICS
Quarterly fund activity3 increased0 reduced0 exited
Institutional Holders of CUE
↗
3 holders
Manager⇅Type⇅Shares⇅Market Value▼% of Total⇅% of Portfolio⇅Action⇅QoQ Change⇅Quarter⇅
Tetragon Partners GP Ltd
CIK 0001515070
Hedge Fund94K$3.0M69.9%0.5%Added—Q2 2026
CITADEL ADVISORS LLC
CIK 0001423053
Hedge Fund26K$809K19.1%0.0%Added—Q2 2026
RENAISSANCE TECHNOLOGIES LLC
CIK 0001037389
Hedge Fund15K$464K11.0%0.0%Added—Q2 2026
Tetragon Partners GP LtdAdded
Hedge Fund
$3.0M· 69.9% of total· 0.5% port· 94K sh· — QoQ· Q2 2026
CITADEL ADVISORS LLCAdded
Hedge Fund
$809K· 19.1% of total· 0.0% port· 26K sh· — QoQ· Q2 2026
RENAISSANCE TECHNOLOGIES LLCAdded
Hedge Fund
$464K· 11.0% of total· 0.0% port· 15K sh· — QoQ· Q2 2026
Loading recent insider activity…
← Stock ownership